Cost-effectiveness of bariatric surgery: should it be universally available?

摘要: This paper is the first to conduct cost-effectiveness analyses of bariatric surgery comparing obese patients with obesity-related diseases people without comorbidities across different BMI categories, using meta-analysis results outcomes for our effectiveness inputs. We find that treatment in general cost-effective whose greater than 35 kg/m(2) or comorbidities, and it even cost-saving super (BMI ≥ 50 kg/m(2)) comorbidities. Our also suggest can be mildly 30 kg/m(2)). The bottom line should universally available all classes people.